Showing results (421-430 of 842) with videos related to

Sort By:
Pageof 85
Genome Research|August 25, 2000
Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7H Davidson, M S Taylor, A Doherty, et al.
Archives of Internal Medicine|July 1, 1999
Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trialM H Davidson, D Hunninghake, K C Maki, et al.
European Heart Journal|February 19, 2013
Diagnosis and treatment of familial hypercholesterolaemiaG Kees Hovingh, Michael H Davidson, John J P Kastelein, et al.
Genes & Development|March 1, 1987
Lineage and fate of each blastomere of the eight-cell sea urchin embryoR A Cameron, B R Hough-Evans, R J Britten, et al.
Development (Cambridge, England)|December 3, 1998
A comparative molecular approach to mesodermal patterning in basal deuterostomes: the expression pattern of Brachyury in the enteropneust hemichordate Ptychodera flavaK J Peterson, R A Cameron, K Tagawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Distribution of repetitive and nonrepetivite sequence transcripts in HeLa mRNAW H Klein, W Murphy, G Attardi, et al.
Lasers in Surgery and Medicine|March 24, 2005
Characterization of measurement artefacts in fluoroptic temperature sensors: implications for laser thermal therapy at 810 nmSean R H Davidson, I Alex Vitkin, Michael D Sherar, et al.
Journal of the American College of Cardiology|December 16, 2014
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular diseaseRobert S Rosenson, Michael H Davidson, Benjamin J Hirsh, et al.
Mechanisms of Development|August 1, 1994
Complexity and organization of DNA-protein interactions in the 5'-regulatory region of an endoderm-specific marker gene in the sea urchin embryoC H Yuh, A Ransick, P Martinez, et al.
American Heart Journal Plus : Cardiology Research and Practice|February 18, 2026
Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?Charles Shear, Michael H Davidson, Marc Ditmarsch, et al.
Pageof 85